Stay updated on Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial
Sign up to get notified when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.

Latest updates to the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision tag on the page updated from v3.6.2 to v3.6.3, indicating the current page version has been refreshed; the underlying study details remain unchanged.SummaryDifference0.1%

- Check15 days agoChange DetectedThe page shows Revision: v3.6.2, replacing the previous Revision: v3.6.0, indicating a minor version update to the page's metadata.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page now shows that recruitment is closed for this study, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, along with a standardization of the Intervention/Treatment label and a revision footer updated to v3.6.0.SummaryDifference0.4%

- Check36 days agoChange DetectedAn update to the page's revision tag from v3.5.4 to v3.5.5 was applied, indicating a backend/content-management update. This signals a page refresh or republishing rather than changes to the study data or listings.SummaryDifference0.1%

- Check58 days agoChange DetectedPublications section updated: the older JCO reference with an Erratum is removed, and a newer JCO publication citation related to HER2-mutant cancers is added. This reflects an updated bibliographic record for results associated with the study.SummaryDifference0.1%

- Check79 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting an incremental site/version change without altering the displayed clinical trial study content.SummaryDifference0.1%

Stay in the know with updates to Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ado-Trastuzumab Emtansine in HER2 Amplified Cancers Clinical Trial page.